Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Charles River Realty Investors is a private equity real estate firm that specializes in the acquisition and development of properties within the life sciences, healthcare, and technology sectors. As an affiliate of National Development, the firm leverages extensive regional expertise to develop sophisticated laboratory and research environments, primarily in the New England market. They manage a series of investment funds focused on value-add opportunities, providing the essential physical infrastructure required by biotech and pharmaceutical companies. The firm's portfolio includes significant lab conversions and purpose-built facilities designed to meet the technical requirements of modern scientific research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Charles River Realty Investors.